| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 05/02/2002 | WO2002034272A2 Methods of improving central nervous system functioning |
| 05/02/2002 | WO2002022080A3 Enhanced first generation adenovirus vaccines expressing codon optimized hiv1-gag, pol, nef and modifications |
| 05/02/2002 | WO2002011677A3 Treatment of hyperproliferative diseases with epidermal growth factor receptor antagonists |
| 05/02/2002 | WO2002008388A3 Stem cell-like cells |
| 05/02/2002 | WO2002005829A3 Methods and formultations with probiotic microorganisms and medicaments |
| 05/02/2002 | WO2001095739A3 Diet which induces ketosis in a canine or feline |
| 05/02/2002 | WO2001094586A3 Non-agonistic antibodies to human gp39, compositions containing, and therapeutic use thereof |
| 05/02/2002 | WO2001091803A3 Methods and compounds for controlled release of recombinant parvovirus vectors |
| 05/02/2002 | WO2001087316A3 Composition and method for increasing testosterone levels |
| 05/02/2002 | WO2001083710A3 Clearance of neoplastic cells from mixed cellular compositions using viruses |
| 05/02/2002 | WO2001077137A9 Albumin fusion proteins |
| 05/02/2002 | WO2001074900A3 Nuclear factor kb inducing factor |
| 05/02/2002 | WO2001066150A3 Highly efficient gene transfer into human repopulating stem cel ls by rd114 pseudotyped retroviral vector particles |
| 05/02/2002 | WO2001062931A3 ANTI-EGFRvIII SCFVS WITH IMPROVED CYTOTOXICITY AND YIELD, IMMUNOTOXINS BASED THEREON, AND METHODS OF USE THEREOF |
| 05/02/2002 | WO2001055393A3 Mhc class ii restricted t cell epitopes from the cancer antigen ny-eso-1 |
| 05/02/2002 | WO2001052667A3 Pet food composition for treating helicobacter species in pets |
| 05/02/2002 | WO2001038394A3 Polypetptides and methods for thymic vaccination |
| 05/02/2002 | WO2001018172A3 Fibroblast growth factor-like polypeptides |
| 05/02/2002 | WO2001000874A3 Cancer associated antigens and uses therefor |
| 05/02/2002 | WO2000078972A3 Regulation with binding cassette transporter protein abc1 |
| 05/02/2002 | WO2000075365A9 COMPOUNDS AND METHODS TO ENHANCE rAAV TRANSDUCTION |
| 05/02/2002 | US20020053092 Generation and recovering transgenic stem cells; obtain gonad, inject transfection mixture, insert expression vector into genome, recover transgenic stem cells |
| 05/02/2002 | US20020052477 Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use |
| 05/02/2002 | US20020052339 Methods for treatment of impulse control disorders |
| 05/02/2002 | US20020052311 Methods and compostions for the treatment and/or diagnosis of neurological diseases and disorders |
| 05/02/2002 | US20020052044 Process for the production of human cartilage implants by means of chondrocytes cultivated in vitro |
| 05/02/2002 | US20020052038 Polypeptide for use in the treatment of viral diseases and cancer |
| 05/02/2002 | US20020052011 Method for evaluating and affecting male fertility |
| 05/02/2002 | US20020051977 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 05/02/2002 | US20020051806 Patterned substrates and methods for nerve regeneration |
| 05/02/2002 | US20020051799 Glucosylated hydroxystilbene compounds for treating skin conditions |
| 05/02/2002 | US20020051776 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications |
| 05/02/2002 | US20020051775 Escherichia coli strain BU-230-98 ATCC Deposit No. 20226 (DSM 12799) |
| 05/02/2002 | US20020051774 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications |
| 05/02/2002 | US20020051773 Escherichia coli strain BU-230-98 ATCC Deposit No. 20226 (DSM 12799) |
| 05/02/2002 | US20020051772 Escherichia coli strain BU-230-98 ATCC Deposit No. 20226 (DSM 12799) |
| 05/02/2002 | US20020051771 Apoptotic entities for use in treatment of T-cell-mediated and inflammatory disorders |
| 05/02/2002 | US20020051766 Treating an aliquot of patient's blood ex vivo with a stressor selected from temperature above or below body temperature, an electromagnetic emission and an oxidative environment, followed by administering back into patient |
| 05/02/2002 | US20020051765 Method of cancer treatment |
| 05/02/2002 | US20020051763 Recombinant viral genome and nucleic acid sequence, carried by one or two plasmid supports, transcomplementing each other and allowing the host cell to produce defective infectious viruses |
| 05/02/2002 | US20020051762 Purified populations of endothelial progenitor cells |
| 05/02/2002 | US20020051761 Synthetic soil-extract materials and medicaments for herpes viruses based thereon |
| 05/02/2002 | US20020050276 Method and bottle for infant feeding |
| 05/02/2002 | EP1202064A2 Method for detecting antibodies to and antigens of fungal and yeast exposures |
| 05/02/2002 | EP1201749A1 Method for producing cartilage implants using chondrocytes grown in-vitro |
| 05/02/2002 | EP1200622A1 Adenovirus carrying gag gene hiv vaccine |
| 05/02/2002 | EP1200616A2 Enhanced delivery via serpin enzyme complex receptor ligands |
| 05/02/2002 | EP1200608A2 Chimeric polypeptides of serum albumin and uses related thereto |
| 05/02/2002 | EP1200607A2 Tet repressor-based transcriptional regulatory proteins |
| 05/02/2002 | EP1200602A1 Dsp-11 dual-specificity map kinase phophatase |
| 05/02/2002 | EP1200596A2 Human synthetases |
| 05/02/2002 | EP1200595A2 Myxoma virus genes for immune modulation |
| 05/02/2002 | EP1200594A2 Protective antigen of epstein barr virus |
| 05/02/2002 | EP1200590A1 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
| 05/02/2002 | EP1200589A1 Modified ciliary neurotrophic factor, method of making and methods of use thereof |
| 05/02/2002 | EP1200584A1 Splice variants of cd40-receptor |
| 05/02/2002 | EP1200569A1 A method for selective electrofusion of at least two fusion partners having cell-like membranes |
| 05/02/2002 | EP1200559A2 Muscle cells and their use in cardiac repair |
| 05/02/2002 | EP1200555A1 Identification of pluripotent pre-mesenchymal, pre-hematopoietic progenitor cell |
| 05/02/2002 | EP1200479A1 Multiple cytokine-antibody complexes |
| 05/02/2002 | EP1200133A1 Manipulation of tissue or organ type using the notch pathway |
| 05/02/2002 | EP1200119A2 Method for down-regulating gdf-8 activity |
| 05/02/2002 | EP1200117A2 Lipoprotein lipase (lpl) variant therapeutics |
| 05/02/2002 | EP1200112A2 Chemokine binding protein of gammaherpesvirus 68 and methods of use therefor |
| 05/02/2002 | EP1200110A1 In vivo induction for enhanced function of isolated hepatocytes |
| 05/02/2002 | EP1200101A1 Methods for transdifferentiation of body tissues |
| 05/02/2002 | CA2436515A1 Ex vivo oxidatively stressed cll cells in chronic lymphocytic leukemia (cll) treatment |
| 05/02/2002 | CA2427070A1 Preferred segments of neural thread protein and methods of using the same |
| 05/02/2002 | CA2426902A1 Methods of improving central nervous system functioning |
| 05/02/2002 | CA2426672A1 Compositions and methods for diagnosis and treatment of cardiovascular disorders |
| 05/02/2002 | CA2426294A1 Nucleic acid generating the abca7 gene, molecules modulating its activity and therapeutic applications |
| 05/02/2002 | CA2425283A1 Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 05/01/2002 | CN1347450A Composition for preservation of infections recombinant adenoviruses |
| 05/01/2002 | CN1347324A Composition for treatment of psoriasis |
| 05/01/2002 | CN1347283A eNOS mutations useful for gene therapy and therapeutic screening |
| 05/01/2002 | CN1346675A Chinese patent medicine for treating paraplegia |
| 05/01/2002 | CN1346673A Chinese patent medicine for treating hyperosteogeny |
| 05/01/2002 | CN1346670A Medicine for treating hyperosteogeny |
| 05/01/2002 | CN1346668A Medicine for preventing and treating myopia and amlyopia |
| 05/01/2002 | CN1346661A Medicine for setting up bone |
| 05/01/2002 | CN1346652A Quick-acting mosquito-repellent antipruritic liquid and its preparing process |
| 05/01/2002 | CN1346641A Freezed dried centipede |
| 05/01/2002 | CN1346640A Freeze dried leech capsule |
| 05/01/2002 | CN1346639A Process for preparing nutritive liquid from oviduct of female Chinese forest frog |
| 05/01/2002 | CN1346638A Granular medicine of coral powder and its application |
| 05/01/2002 | CN1346637A Animal blood mixed dominant gene type embryo product |
| 05/01/2002 | CN1346636A 活性鹿血粉胶囊 Active deer blood powder capsules |
| 05/01/2002 | CN1083724C Traditional Chinese medicine preparation for treating puerperal fever and gynaopathy uterine bleeding |
| 05/01/2002 | CN1083723C Thrombolytic and hypotensor pill |
| 05/01/2002 | CN1083722C Plaster for treating hyperosteogeny and protrusion of lumbar vertebral disc |
| 05/01/2002 | CN1083720C Chinese patent drug for curing cirrhosis and splenceratosis disease |
| 05/01/2002 | CN1083719C Sphinx extract oral liquid |
| 04/30/2002 | US6380366 Shark cartilage extract:process of making, methods of using and compositions thereof |
| 04/30/2002 | US6379967 A mutant viral gene that prevents viral replication in human cells; gene therapy |
| 04/30/2002 | US6379962 Polymer scaffold having microporous polymer struts defining interconnected macropores |
| 04/30/2002 | US6379950 Recombinant, active caspases and uses thereof |
| 04/30/2002 | US6379902 Mycrobacterial proteins, microorganisms producing same and uses of said proteins in vaccines and for detecting tuberculosis |
| 04/30/2002 | US6379901 Detecting cancer cells that express a human leukocyte antigen molecule using a nonapeptide derived from the tumor rejection antigen precursor; mixing cells and nonapeptide to form complexes; expose to cytolytic cells and determine lysis |
| 04/30/2002 | US6379715 Method for treatment of psoriasis |
| 04/30/2002 | US6379710 Membranes; three-dimensional shapes |